financetom
OMCL
financetom
/
Healthcare
/
OMCL
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Omnicell, Inc.OMCL
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally.

The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.

It also provides central pharmacy automation solutions; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems.

In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings.

Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001.

Omnicell, Inc. was incorporated in 1992 and is headquartered in Santa Clara, California.

Latest News >
Tandem Diabetes Care to Release New Update as Battery Issues Persist With X2 Insulin Pump
Tandem Diabetes Care to Release New Update as Battery Issues Persist With X2 Insulin Pump
Aug 12, 2024
05:06 PM EDT, 08/12/2024 (MT Newswires) -- Tandem Diabetes Care ( TNDM ) said Monday that some users continue to face rapid battery depletion of its t:slim X2 insulin pump and indicated it will release a newer version of the application to address the remaining issues. The company initially recalled Apple's ( AAPL ) iOS t:connect mobile app in the...
Arcosa Prices $600 Million Notes Due 2032
Arcosa Prices $600 Million Notes Due 2032
Aug 12, 2024
05:08 PM EDT, 08/12/2024 (MT Newswires) -- Arcosa ( ACA ) said Monday it priced its $600 million private offering of 6.875% senior notes due 2032. The offering is slated to close on Aug. 26, the company said. Net proceeds from the offering, together with borrowings, will be used to fund the $1.2 billion acquisition of Stavola's construction materials business,...
BMO to Redeem $1 Billion Series J Medium-Term Notes First Tranche
BMO to Redeem $1 Billion Series J Medium-Term Notes First Tranche
Aug 12, 2024
05:07 PM EDT, 08/12/2024 (MT Newswires) -- Bank of Montreal ( BERZ ) Monday said it will redeem all of its $1 billion Series J Medium-Term Notes (Non-Viability Contingent Capital [NVCC]), First Tranche due Sept. 17, 2029. The redemption will occur Sept. 17. The Notes are redeemable at a redemption price equal to 100% of the principal amount thereof, plus...
Sienna Senior Living Raising $125 Million in a Bought-Deal Share Offering
Sienna Senior Living Raising $125 Million in a Bought-Deal Share Offering
Aug 12, 2024
05:06 PM EDT, 08/12/2024 (MT Newswires) -- Sienna Senior Living ( LWSCF ) after trade Monday said it is raising $125 million in a bought-deal share offering.. Sienna is selling a syndicate of underwriters 8.34-million shares priced at $15.00 each. It also granted the underwriters an over-allotment option of a further 1.25-million shares if demand warrants. If the over-allotment option...
Copyright 2023-2026 - www.financetom.com All Rights Reserved